Calabash Brothers: Company Injecting Cefoperazone Sodium for Injection Through Generic Drug Consistency Evaluation

date
18/07/2025
On July 17th, Huluo announced that the company has recently received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration for the injection of Cefoperazone sodium. This drug has passed the evaluation of generic drug quality and efficacy consistency. Cefoperazone sodium for injection is a third-generation cephalosporin antibiotic, suitable for lower respiratory tract infections, urinary tract infections, gynecological infections, bacteremia/sepsis, skin and soft tissue infections, intra-abdominal infections, bone and joint infections, and central nervous system infections caused by susceptible bacteria.